Standard BioTools - 13 Year Stock Price History | LAB
Historical daily share price chart and data for Standard BioTools since 2011 adjusted for splits and dividends. The latest closing stock price for Standard BioTools as of November 19, 2024 is 1.51.
- The all-time high Standard BioTools stock closing price was 48.89 on March 05, 2014.
- The Standard BioTools 52-week high stock price is 3.04, which is 101.3% above the current share price.
- The Standard BioTools 52-week low stock price is 1.21, which is 19.9% below the current share price.
- The average Standard BioTools stock price for the last 52 weeks is 2.21.
| Standard BioTools Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2024 | 2.2044 | 2.2200 | 2.9200 | 1.4200 | 1.5100 | -31.67% |
| 2023 | 2.1764 | 1.3000 | 3.0500 | 1.3000 | 2.2100 | 88.89% |
| 2022 | 2.1587 | 3.7200 | 3.9900 | 0.9335 | 1.1700 | -70.15% |
| 2021 | 5.5255 | 6.1700 | 7.4100 | 3.6300 | 3.9200 | -34.67% |
| 2020 | 5.0805 | 3.4900 | 11.4300 | 1.2400 | 6.0000 | 72.41% |
| 2019 | 8.6295 | 8.5900 | 14.3600 | 2.3000 | 3.4800 | -59.63% |
| 2018 | 6.7885 | 6.2300 | 8.8300 | 4.8600 | 8.6200 | 46.35% |
| 2017 | 5.1843 | 7.5900 | 8.3300 | 2.7100 | 5.8900 | -19.09% |
| 2016 | 8.0352 | 10.1200 | 10.9100 | 4.3400 | 7.2800 | -32.65% |
| 2015 | 23.9509 | 33.6100 | 45.5400 | 7.3800 | 10.8100 | -67.95% |
| 2014 | 32.9927 | 36.8000 | 48.8900 | 22.0600 | 33.7300 | -11.89% |
| 2013 | 20.9563 | 14.5000 | 39.3700 | 14.2700 | 38.2820 | 167.52% |
| 2012 | 14.7265 | 13.3200 | 17.1500 | 12.6000 | 14.3100 | 8.74% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.562B | $0.106B |
| Standard BioTools Inc. is a solution provider in health and disease using its proprietary mass cytometry and microfluidics technologies. It serves academic, government, pharmaceutical, biotechnology, plant and animal research and clinical laboratories. Standard BioTools Inc., formerly known as Fluidigm Corporation, is based in SOUTH SAN FRANCISCO, Calif. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tempus AI (TEM) | United States | $8.497B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $5.276B | 164.53 |
| Hims & Hers Health (HIMS) | United States | $5.141B | 130.72 |
| Privia Health (PRVA) | United States | $2.533B | 211.10 |
| Enovis (ENOV) | United States | $2.529B | 17.15 |
| IRhythm Technologies (IRTC) | United States | $2.362B | 0.00 |
| Azenta (AZTA) | United States | $2.001B | 99.78 |
| Omnicell (OMCL) | United States | $1.964B | 64.26 |
| Clover Health Investments (CLOV) | United States | $1.644B | 0.00 |
| 10x Genomics (TXG) | United States | $1.643B | 0.00 |
| Schrodinger (SDGR) | United States | $1.378B | 0.00 |
| Phreesia (PHR) | United States | $1.072B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.650B | 0.00 |
| Talkspace (TALK) | United States | $0.522B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.520B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.483B | 83.60 |
| Health Catalyst (HCAT) | United States | $0.459B | 0.00 |
| TruBridge (TBRG) | United States | $0.244B | 71.22 |
| Pulmonx (LUNG) | United States | $0.237B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.214B | 0.00 |
| American Well (AMWL) | United States | $0.122B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.107B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.075B | 0.00 |
| HeartBeam (BEAT) | United States | $0.067B | 0.00 |
| 111 (YI) | China | $0.053B | 0.00 |
| CareCloud (CCLD) | United States | $0.046B | 0.00 |
| Zepp Health (ZEPP) | China | $0.040B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.040B | 0.00 |
| Outset Medical (OM) | United States | $0.039B | 0.00 |
| Movano (MOVE) | United States | $0.020B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.019B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.014B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.013B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.012B | 0.00 |
| MSP Recovery (LIFW) | United States | $0.010B | 0.00 |
| Precipio (PRPO) | United States | $0.009B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.006B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.006B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.004B | 0.00 |
| Syra Health (SYRA) | United States | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.002B | 0.00 |
| Zhongchao (ZCMD) | China | $0.002B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |